HCRN Directory

Rectal

HCRN-GI03-53

A Phase II Trial of Preoperative Capecitabine Plus Irinotecan Followed by Combined Modality Capecitabine and Radiation for Locally Advanced Rectal Cancer – GI03-53

Status

Closed

Cancer Types

Rectal

Locations